Background Randomized trials have demonstrated a benefit associated with adjuvant
therapy for pancreatic cancer, and retrospective studies have demonstrated improvements …

Prognostic Factors Following Curative Resection for Pancreat... : Annals of Surgery Prognostic
Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based …

Background The 1-year disease-related mortality after resection for pancreatic cancer is
approximately 30%. This study examined potential preoperative parameters that would help …

Objective: To determine long-term survival after pancreatoduodenectomy for pancreatic
ductal adenocarcinoma and to identify clinical factors associated with long-term survival …

OBJECTIVE: The aim of this study was to determine the long term survival of patients with
pancreatic adenocarcinoma who underwent surgical resection and to assess the …

Background Most reports of patients undergoing resection for pancreatic adenocarcinoma
report estimated (actuarial) 5-year survival rates. Actual 5-year survival is rarely described …

Introduction Actual 5-year survival rates of 10–18% have been reported for patients with
resected pancreatic adenocarcinoma (PC), but the use of multimodality therapy was …

AIM: To retrospectively analyze factors affecting the long-term survival of patients with
pancreatic cancer who underwent pancreatic resection. METHODS: From January 2000 to …

BACKGROUND: Surgical resection remains the only potentially curative option for patients
with pancreatic adenocarcinoma (PAC). Advances in surgical technique and perioperative …

Purpose Adjuvant chemotherapy improves patient survival rates after resection for
pancreatic adenocarcinoma, but the optimal duration and time to initiate chemotherapy is …